Geovax Labs Inc WT (GOVXW)

$0.11 +0.00 (0.54%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	N/A
Revenue (ttm)	0.00
Net Income (ttm)	-25.97M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	19,100
Avg Vol	38,660
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	15%
Beta	N/A
Analysts	Strong Sell
Price Target	N/A

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology

Sector: Healthcare

Phone: (678) 384-7220

Fax: (678) 384-7281

Website: www.geovax.com

Address:

1900 Lake Park Drive, Suite 380, Smyrna, United States